Neuren Pharmaceuticals and Nickel Industries have both published their first-half financial results, outlining mid-year performance and forward guidance for shareholders. The disclosures highlight divergent operational trends across the healthcare and resource sectors as companies conclude their H1 reporting cycles.

Nickel Industries has released its second-quarter financial results, providing an update on its performance for the period.